Pharming Group to report third quarter 2025 financial results and provide business update on November 6
Pharming Group (Nasdaq: PHAR) will report preliminary unaudited Q3 2025 financial results and provide a business update on Thursday, November 6, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Pharming Group (Nasdaq: PHAR) will report preliminary unaudited Q3 2025 financial results and provide a business update on Thursday, November 6, 2025.
Management will host a conference call and webcast for analysts and investors on the same day at 13:30 CET / 07:30 ET. Investors must register in advance for the conference call or webcast; dial-in attendees will receive a unique PIN and only dial-in participants can ask questions. The webcast will be available on the company’s Investors/Financial Documents page and a replay will be posted shortly after the event.
Details
News Market Reaction – PHAR
On Oct 23, the day this news came out, PHAR closed 13.05% above the previous close.
Data tracked by StockTitan Argus for the Oct 23 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Leiden, the Netherlands, October 23, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the third quarter 2025 and provide a business update on Thursday, November 6, 2025.
Management will host a conference call and webcast for analysts and investors on the same day at 13:30 CET/07:30 am ET.
To participate in the conference call or to watch the live webcast, please register in advance using the links below.
Conference call registration:
https://register-conf.media-server.com/register/BI1b6a1a63294c427f91ab7b24a7c6484b
Once registered, dial-in information and a unique PIN will be provided, allowing access to the call.
Please note, the Company will only take questions from dial-in attendees.
Webcast registration:
https://edge.media-server.com/mmc/p/vb724dzx
The webcast will also be accessible on the Pharming website at Investors/Financial Documents, and a replay will be available shortly after the event.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with a significant proportion of its employees based in the U.S.
For more information, visit www.pharming.com and find us on LinkedIn.
For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com
LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.